Fulcrum Therapeutics, Inc.·4

Mar 20, 4:15 PM ET

Horn Patrick Taylor 4

4 · Fulcrum Therapeutics, Inc. · Filed Mar 20, 2024

Insider Transaction Report

Form 4
Period: 2024-03-18
Horn Patrick Taylor
Chief Medical Officer
Transactions
  • Award

    Stock Option (right to buy)

    2024-03-18+400,000400,000 total
    Exercise: $10.12Exp: 2034-03-17Common Stock (400,000 underlying)
Footnotes (1)
  • [F1]This option was granted on March 18, 2024 and is scheduled to vest 25% on the first anniversary of the vesting commencement date of March 18, 2024. The remainder of the shares underlying the grant shall vest in equal quarterly installments over the following three years until the fourth anniversary of the vesting commencement date, subject to continued service.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4